CureDuchenne Ventures Commits $5M to Startup With CRISPR-Based DMD Therapy – Genetic Engineering & Biotechnology News
|
CureDuchenne Ventures Commits $5M to Startup With CRISPR-Based DMD Therapy
Genetic Engineering & Biotechnology News The venture philanthropy arm of the nonprofit CureDuchenne has committed $5 million in seed financing toward a startup focused on using gene editing technologies such as CRISPR/Cas9 to permanently correct most mutations causing Duchenne muscular … |
